Toxin Reviews is a premier academic journal focused on the critical field of Toxicology, published by Taylor & Francis Inc. Established with an aim to foster research and disseminate knowledge, this journal has been pivotal since its inception in 1982 and continues to be a leading platform for both emerging and established researchers. With an impressive impact factor and ranked in the 75th percentile among its peers in the Scopus categories, it serves as an essential resource for scientists, practitioners, and students interested in understanding the complexities of toxins and their effects on health. The journal provides an Open Access platform, enhancing visibility and accessibility of research findings to a broader audience. Covering a wide scope, Toxin Reviews plays a vital role in bridging gaps between toxicological research and practical applications, ensuring that rigorous scientific inquiry translates into real-world solutions.

JOURNAL OF ANALYTICAL TOXICOLOGY, published by Oxford University Press Inc, stands as a leading platform in the field of analytical chemistry and toxicology, focusing on the rigorous exploration of methodologies and advancements in the detection of toxic substances. Since its inception in 1977, this journal has continually contributed to the scientific community, providing researchers and professionals with vital insights into chemical health, safety, and environmental implications. With an impressive Q1 ranking in both Analytical Chemistry and Chemical Health and Safety, along with reputable Q2 rankings in Environmental Chemistry and Toxicology, the journal maintains its critical standing in vibrant academic communities, ensuring the dissemination of high-quality research. Although it currently does not offer open access, articles are made available via institutional subscriptions, allowing widespread access to its valuable findings. Located in the United States, the journal contains a wealth of knowledge poised to benefit scientists and scholars engaged in toxicological research, emphasizing its importance in enhancing public health and safety.

Exposure and Health is a pioneering journal published by Springer, specializing in the interdisciplinary fields of health, toxicology, and environmental sciences. With an ISSN of 2451-9766 and E-ISSN of 2451-9685, this open-access journal exemplifies a commitment to disseminating high-quality research that informs public health practices and policies globally. Situated in the Netherlands, it boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple categories in the 2023 Scopus rankings, including Health, Toxicology and Mutagenesis, Pollution, and Water Science and Technology. The journal is dedicated to advancing knowledge on the interactions between environmental factors and health outcomes, making it a vital resource for researchers, professionals, and students in these critical fields. Exposure and Health actively encourages submissions that address the challenges of exposure assessment, risk management, and the promotion of sustainable public health initiatives.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

Revista del Cuerpo Medico del Hospital Nacional Almanzor Aguinaga Asenjo is a prominent medical journal published by the renowned Hospital Nacional Almanzor Aguinaga Asenjo in Peru. With the ISSN 2225-5109 and E-ISSN 2227-4731, this open-access journal has been serving the medical community since its inception in 2019. It aims to disseminate vital research and insights in the fields of health and medicine, providing a platform for the exchange of knowledge on critical issues affecting public health and healthcare policy in Latin America. Although classified in the Q4 category for both Health (social science) and Medicine (miscellaneous) in 2023, its essential contributions to health professions and policy add significant value to researchers and practitioners alike. Positioned within the context of a rapidly evolving healthcare landscape, the journal is crucial for fostering a better understanding of the challenges and innovations in healthcare delivery and medical practice. Researchers, professionals, and students looking to deepen their understanding of these fields will find this journal invaluable as it continues to grow and adapt through 2024 and beyond.

The University of Toronto Medical Journal is a prominent publication within the field of General Medicine, dedicated to the dissemination of innovative research and critical discourse relevant to the medical community. Established in 1945 and published by the University of Toronto Medical Society, this journal serves as a platform for medical students and professionals to share their insights, fostering an environment of learning and collaboration. Over the years, the journal has played a crucial role in nurturing future leaders in medicine, contributing significantly to the academic landscape, despite its current Scopus rank of #511 out of 636 in its category, reflecting its niche yet vital presence. With an ISSN of 0833-2207 and an E-ISSN of 1913-5440, the journal remains a reference point for those passionate about medical research and education in Canada and beyond. Although it does not operate under an open-access model, the journal’s commitment to academic rigor and integrity continues to make it an essential resource for students, researchers, and healthcare professionals alike.

Journal of the Scientific Society is a prominent platform dedicated to the dissemination of innovative research and scholarly articles across the diverse fields of science and technology. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, this Open Access journal has been committed to making high-quality research accessible to all since 2012. With an ISSN of 0974-5009 and an E-ISSN of 2278-7127, the journal caters to a global audience, facilitating knowledge exchange among researchers, professionals, and students. Positioned within an evolving academic landscape, the journal aims to foster interdisciplinary dialogue and collaboration through its multidisciplinary scope. The Journal of the Scientific Society not only serves as a valuable resource for cutting-edge scientific ideas but also contributes to the advancement of knowledge in its respective fields, making it an essential read for anyone invested in the future of scientific inquiry.

The Journal of Toxicological Sciences, published by the Japanese Society of Toxicological Sciences, is a prominent academic journal dedicated to the comprehensive study of toxicology and its related fields. Since its inception in 1976, the journal has provided a vital platform for researchers and professionals to disseminate innovative findings and insights in toxicology, with a focus on both experimental and clinical studies. Positioned in the Q3 quartile across various relevant categories, including Medicine (miscellaneous) and Toxicology as of 2023, the journal plays an essential role in advancing our understanding of toxic substances and their effects on biological systems. Although currently not open access, the journal maintains high academic standards and is indexed in Scopus, ranking #96 in Toxicology. Offering unique perspectives from Japan, it encourages global collaboration and discourse among toxicologists, making it an invaluable resource for students, researchers, and industry professionals alike.